TRAW
Traws Pharma IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$22.57M
P/E Ratio
—
EPS
$-1.87
Beta
1.47
52W High
$3.27
52W Low
$0.99
50-Day MA
$1.66
200-Day MA
$1.89
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Traws Pharma Inc
Traws Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer in the United States. The company is headquartered in Newtown, Pennsylvania.
Fundamentals
| Revenue (TTM) | $2.73M |
| Gross Profit (TTM) | $2.73M |
| EBITDA | $-19.51M |
| Operating Margin | -718.00% |
| Return on Equity | -5639.00% |
| Return on Assets | -90.10% |
| Revenue/Share (TTM) | $0.30 |
| Book Value | $-0.07 |
| Price-to-Book | 2.16 |
| Price-to-Sales (TTM) | 8.26 |
| EV/Revenue | 7.22 |
| EV/EBITDA | 0.33 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $15.15M |
| Float | $11.73M |
| % Insiders | 10.46% |
| % Institutions | 29.80% |
Historical Volatility
HV 10-Day
141.11%
HV 20-Day
150.90%
HV 30-Day
154.04%
HV 60-Day
123.42%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($5.50 target)
2
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026